Synairgen Plc is a holding company, which engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease, and severe viral infections. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Synairgen?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Synairgen market cap is $10.48M.
What is the 52-week high for Synairgen?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Synairgen 52 week high is $0.068 as of October 10, 2025.
What is the 52-week low for Synairgen?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Synairgen 52 week low is $0.0001 as of October 10, 2025.
What is Synairgen stock price today?
Synairgen stock price today is $0.0002.
What was Synairgen stock price yesterday?
Synairgen stock price yesterday was $0.0001.
What is the 50-day moving average of Synairgen?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Synairgen 50-day moving average is $0.0002.
